For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 7vPnC / 13vPnC | 13vPnC administered as a single 0.5 mL dose IM. Participants had previously received 7vPnC in study D118-P8. Adverse Events include Local reactions and Systemic events collected on the diary card and reported in the diary-related case report form (systematic assessment) and other Adverse Events collected on the case report form (non-systematic methods). Other Adverse Events N=22; Local reactions N=38; Systemic events N=38. | None | None | 0 | 38 | 38 | 38 | View |
| MnCC / 13vPnC | 13vPnC administered as a single 0.5 mL dose IM. Participants had previously received MnCC in study D118-P8. Adverse Events include Local reactions and Systemic events collected on the diary card and reported in the diary-related case report form (systematic assessment) and other Adverse Events collected on the case report form (non-systematic methods). Other Adverse Events N=20; Local reactions N=36; Systemic events N=36. | None | None | 0 | 36 | 36 | 36 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Lymphoid tissue hyperplasia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA | View |
| Palpitations | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA | View |
| Congenital flat feet | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | MedDRA | View |
| Cerumen impaction | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | MedDRA | View |
| Ear congestion | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | MedDRA | View |
| Ear pain | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | MedDRA | View |
| Diarrhoea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Injection site pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Pyrexia | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Injection site swelling | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Seasonal allergy | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA | View |
| Otitis externa | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pharyngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Acute sinusitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Bronchitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Gastritis viral | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Sinusitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Viral upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Contusion | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Joint sprain | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Ankle fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Avulsion fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Clavicle fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Concussion | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Excoriation | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Hand fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Muscle strain | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Traumatic brain injury | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| Decreased appetite | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA | View |
| Dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA | View |
| Arthralgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA | View |
| Patellofemoral pain syndrome | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA | View |
| Skin papilloma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Hypersomnia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Somnolence | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Presyncope | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Syncope | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Insomnia | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA | View |
| Haematuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA | View |
| Dysmenorrhoea | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA | View |
| Gynaecomastia | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA | View |
| Asthma | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Oropharyngeal pain | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Rhinitis allergic | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Cough | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Nasal congestion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Respiratory disorder | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Acne | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Dermatitis contact | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Ingrowing nail | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Tenderness: Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Tenderness: Significant | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Swelling: Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Swelling: Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Swelling: Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Redness: Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Redness: Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Redness: Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reaction | View |
| Fever ≥38 degrees C but ≤39 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Irritability | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Irritability: Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Irritability: Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Increased sleep | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Increased sleep: Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Increased sleep: Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Increased sleep: Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Decreased sleep | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Decreased sleep: Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Decreased sleep: Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Rash | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Rash: Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Decreased appetite: Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |
| Decreased appetite: Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Event | View |